Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
6.48
+0.04 (0.62%)
At close: Feb 11, 2026, 4:00 PM EST
6.47
-0.01 (-0.15%)
After-hours: Feb 11, 2026, 7:41 PM EST
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $347.25 million as of February 11, 2026. Its market cap has increased by 61.06% in one year.
Market Cap
347.25M
Enterprise Value
217.27M
1-Year Change
61.06%
Ranking
Category
Stock Price
$6.48
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $347.25M, an increase of 100.53%. That is a compound annual growth rate of 12.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 345.10M | 20.83% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 373.43M |
| Aura Biosciences | 365.14M |
| Century Therapeutics | 350.31M |
| Puma Biotechnology | 346.69M |
| Rocket Pharmaceuticals | 346.31M |
| Immix Biopharma | 338.31M |
| Aldeyra Therapeutics | 334.51M |
| Atea Pharmaceuticals | 323.44M |